Overview


According to FutureWise analysis the market for latin america next generation sequencing in 2023 is US$ 0.34 billion, and is expected to reach US$ 1.46 billion by 2031 at a CAGR of 19.82%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America Next Generation Sequencing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Latin America Next Generation Sequencing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Pacific Biosciences of California, Inc.
  • Qiagen N.V.
  • Oxford Nanopore Technologies Ltd
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • PerkinElmer, Inc.
  • F. Hoffmann-La Roche AG
  • 10x Genomics, Inc..
  • Macrogen Inc.
  • Partek Inc.
  • Agilent Technologies Inc.
  • Genomatix Software GmbH
  • GATC Biotech Ag

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Consumables
    • Sample Preparation Consumables
      • DNA Fragmentation and Amplification
      • Library Preparation and Target Enrichment
      • Quality Control
    • Other Consumables
  • NGS Platforms/Instruments
    • Illumina NGS Platforms/Instruments
    • Thermo Fisher Scientific NGS Platforms/Instruments
    • Pacific Biosciences NGS Platforms/Instruments
    • Oxford Nanopore NGS Platforms/Instruments
    • Others
  • Software
  • Services

By Sequencing Type

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing
  • Others

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others

By Application

  • Clinical Application
    • Oncology
    • Reproductive Health Diagnostics
      • Non-Invasive Pre-natal Testing
      • Carrier Screening
      • In-Vitro fertilization
      • Newborn Screening
    • Cardiovascular
    • Others
  • Research Application
    • Drug Discovery
    • Agriculture and Animal Research
    • Others

By End user

  • Clinical Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

By Region

  • Brazil
  • Venezuela
  • Argentina
  • Rest of Latin America

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Latin America Next Generation Sequencing Market By Type, By Sequencing Type, By Technology, By Application, By End user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— Brazil, Venezuela, Argentina, Rest of Latin America
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Latin America Next Generation Sequencing Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Latin America Next Generation Sequencing Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Latin America Next Generation Sequencing Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Latin America Next Generation Sequencing Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Consumables
         1.1. Sample Preparation Consumables
          1.1.1. DNA Fragmentation and Amplification
          1.1.2. Library Preparation and Target Enrichment
          1.1.3. Quality Control
         1.2. Other Consumables
        2. NGS Platforms/Instruments
         2.1. Illumina NGS Platforms/Instruments
         2.2. Thermo Fisher Scientific NGS Platforms/Instruments
         2.3. Pacific Biosciences NGS Platforms/Instruments
         2.4. Oxford Nanopore NGS Platforms/Instruments
         2.5. Others
        3. Software
        4. Services

  • 8.   Latin America Next Generation Sequencing Market, By Sequencing Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Whole Genome Sequencing
        2. Whole Exome Sequencing
        3. Targeted Sequencing
        4. Others

  • 9.   Latin America Next Generation Sequencing Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Sequencing by Synthesis
        2. Ion Semiconductor Sequencing
        3. Sequencing by Ligation
        4. Single-Molecule Real-Time Sequencing
        5. Nanopore Sequencing
        6. Others

  • 10.   Latin America Next Generation Sequencing Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Clinical Application
         1.1. Oncology
         1.2. Reproductive Health Diagnostics
          1.2.1. Non-Invasive Pre-natal Testing
          1.2.2. Carrier Screening
          1.2.3. In-Vitro fertilization
          1.2.4. Newborn Screening
         1.3. Cardiovascular
         1.4. Others
        2. Research Application
         2.1. Drug Discovery
         2.2. Agriculture and Animal Research
         2.3. Others

  • 11.   Latin America Next Generation Sequencing Market, By End user Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Clinical Diagnostic Laboratories
        2. Pharmaceutical and Biotechnology Companies
        3. Academic and Research Institutes
        4. Others

  • 12.   Latin America Next Generation Sequencing Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Latin America Landscape - Key Players, Revenue and Presence
        2. Latin America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Latin America Emerging Companies
        4. Latin America - Market Share Analysis and Key Regional Players
        5. Latin America Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Illumina, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Pacific Biosciences of California, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Qiagen N.V.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Oxford Nanopore Technologies Ltd
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bio-Rad Laboratories, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Beckman Coulter, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PerkinElmer, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. F. Hoffmann-La Roche AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. 10x Genomics, Inc..
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Macrogen Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Partek Inc.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Agilent Technologies Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Genomatix Software GmbH
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. GATC Biotech Ag
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 15.  15 GATC Biotech Ag
    •    14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
  • 16.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11